What Researchers Did
Researchers conducted a retrospective analysis of institutional data from 2005 to 2009 to assess the efficacy of hyperbaric oxygen therapy (HBO) as an adjunctive treatment for necrotizing soft tissue infections (NSTIs).
What They Found
Among 80 identified cases of NSTI, in-hospital mortality was 16% in the HBO group and 19% in the non-HBO group, showing no significant difference (P = 0.77). Similarly, the amputation rate for extremity NSTI did not significantly differ between HBO (25%) and non-HBO (17%) patients (P = 0.46).
What This Means for Canadian Patients
Canadian patients with necrotizing soft tissue infections may not benefit from adjunctive hyperbaric oxygen therapy in terms of reducing mortality or amputation rates. This suggests that current standard treatments, including surgical debridement and antibiotics, remain the primary and most effective interventions.
Canadian Relevance
This study has no direct Canadian connection as it was conducted at a single institution outside of Canada.
Study Limitations
A key limitation of this study is its retrospective, single-center design, which may limit the generalizability of the findings.